Since 2002, BioCrossroads has worked to catalyze innovation and collaboration within Indiana’s life sciences sector. The sector has grown at a remarkable pace and has generated billions of dollars in revenue for the state with $79 billion in economic impact in 2021. BioCrossroads plays a critical role by convening academic, philanthropic, and cross-sector employer partners, enhancing research development, and working to attract life sciences businesses, innovation, and talent to Indiana.  

This unique collaborative approach has proven to be successful in times of need. At the onset of the COVID-19 pandemic, BioCrossroads played a key role convening Indiana’s life science and healthcare partners troubleshoot COVID testing, vaccine development and deployment, and other needs for Indiana residents.  

The Richard M. Fairbanks Foundation has awarded $11.5 million to BioCrossroads since 2003 to advance the economic vitality of Indianapolis. 

Additional Posts

$1.15 Million Investment Will Help More Indianapolis Students Navigate Decisions Around Drugs, Alcohol

Claire Fiddian-Green is the President & CEO of the Richard M. Fairbanks Foundation. As part of our effort to prevent substance misuse among young people, the Richard M. Fairbanks Foundation today announced a $1.15 million investment to help 29 Marion County K-12 schools implement drug prevention programs. The five grant recipients are the Metropolitan School Districts […]

Indianapolis eLearning Fund Announces Statewide Virtual Hub in Partnership with the College Football Playoff Foundation

A collaborative of local funders and nonprofit organizations launched the Indianapolis eLearning Fund on April 8th in partnership with the Mayor’s Office of Education Innovation to assist Hoosier educators and families navigate the COVID-19 landscape.